PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：8
|
作者：
MODIG, H
BORGSTROM, S
NILSSON, I
WESTMAN, G
机构：
[1] MALMO GEN HOSP,DEPT ONCOL,S-21401 MALMO,SWEDEN
[2] OREBRO REG HOSP,DEPT ONCOL,OREBRO,SWEDEN
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90015-K
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thirteen postmenopausal women with advanced local or metastatic breast cancer were treated with the antiestrogen toremifene at a daily dose of 200 mg. All patients had failed previous treatment with different types of endocrine therapy and/or cytotoxic drugs. Objective response was only seen in one patient. Treatment was usually well tolerated but in three cases the drug had to be withdrawn due to side effects. © 1990.
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [1] PHASE-II STUDY OF HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER PROGRESSING DURING TAMOXIFENE TREATMENT
    JONSSON, PE
    MALMBERG, M
    BERGLJUNG, L
    INGVAR, C
    ERICSSON, M
    RYDEN, S
    NILSSON, I
    TERJE, IJ
    ANTICANCER RESEARCH, 1991, 11 (02) : 873 - 876
  • [2] PHASE-II CLINICAL-STUDY OF TOREMIFENE IN PATIENTS WITH METASTATIC BREAST-CANCER - PRELIMINARY COMMUNICATION
    MODIG, H
    BORGSTROM, S
    NILSSON, I
    WESTMAN, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 235 - 236
  • [3] HIGH-DOSE IFOSFAMIDE AND MESNA IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    SANCHIZ, F
    MILLA, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S91 - S92
  • [4] A PHASE-II STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 16 - 18
  • [5] PHASE-II STUDY OF TAMOXIFEN AND HIGH-DOSE RETINYL ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER
    BOCCARDO, F
    CANOBBIO, L
    RESASCO, M
    DECENSI, AU
    PASTORINO, G
    BREMA, F
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (05) : 503 - 506
  • [6] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
    LEVI, JA
    BEITH, JM
    SNYDER, RD
    TATTERSALL, MH
    BELL, D
    WHEELER, H
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (05): : 474 - 478
  • [7] PHASE-I CLINICAL AND PHARMACOKINETICS STUDY OF HIGH-DOSE TOREMIFENE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    BISHOP, J
    MURRAY, R
    WEBSTER, L
    PITT, P
    STOKES, K
    FENNESSY, A
    OLVER, I
    LEBER, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) : 174 - 178
  • [8] PHASE-II TRIALS WITH TOREMIFENE IN ADVANCED BREAST-CANCER - A REVIEW
    VALAVAARA, R
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 : S31 - S35
  • [9] PHASE-II TRIAL OF HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    SCINTO, AF
    CERCATO, MC
    BOTTI, C
    TONACHELLA, R
    FERRARESI, V
    DELBIANCO, S
    SACCHI, I
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1285 - 1288
  • [10] SAFETY AND EFFICACY OF TOREMIFENE IN BREAST-CANCER PATIENTS - A PHASE-II STUDY
    VALAVAARA, R
    PYRHONEN, S
    HEIKKINEN, M
    RISSANEN, P
    BLANCO, G
    NORDMAN, E
    TASKINEN, P
    HOLSTI, LR
    HAJBA, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 229 - 231
12345